title: Characterization of the MUC1.Tg/MIN transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas.
abstract: A bigenic MUC1.Tg/MIN mouse model was developed by crossing Apc/(MIN/+) (MIN) mice with human MUC1 transgenic mice to evaluate MUC1 antigen-specific immunotherapy of intestinal adenomas. The MUC1.Tg/MIN mice developed adenomas at a rate comparable to that of MIN mice and had similar levels of serum MUC1 antigen. A MUC1-based vaccine consisting of MHC class I-restricted MUC1 peptides, a MHC class II-restricted pan-helper peptide, unmethylated CpG oligodeoxynucleotide and GM-CSF caused flattening of adenomas and significantly reduced the number of large adenomas. Immunization was successful in generating a MUC1-directed immune response evidenced by increased MUC1 peptide-specific anti-tumor cytotoxicity and IFN-gamma secretion by lymphocytes.
authors: Department of Immunobiology, The University of Arizona, Tucson, AZ 85724, USA. akporiay@email.arizona.edu
authors: Emmanuel T
authors: ET
authors: Akporiaye
authors: Deborah
authors: D
authors: Bradley-Dunlop
authors: Sandra J
authors: SJ
authors: Gendler
authors: Pinku
authors: P
authors: Mukherjee
authors: Cathy S
authors: CS
authors: Madsen
authors: Tobias
authors: T
authors: Hahn
authors: David G
authors: DG
authors: Besselsen
authors: Sharon M
authors: SM
authors: Dial
authors: Haiyan
authors: H
authors: Cui
authors: Katrina
authors: K
authors: Trevor
mesh_terms: D000236:Adenoma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D000276:Adjuvants, Immunologic; D000595:Amino Acid Sequence; D000818:Animals; D019496:Cancer Vaccines / Q000008:administration & dosage / Q000276:immunology; D004195:Disease Models, Animal; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D007414:Intestinal Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D008969:Molecular Sequence Data; D018396:Mucin-1 / Q000008:administration & dosage / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D009838:Oligodeoxyribonucleotides / Q000008:administration & dosage / Q000276:immunology; D010446:Peptide Fragments / Q000008:administration & dosage / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D014611:Vaccination
chemical_list: D000276:Adjuvants, Immunologic; C408982:CPG-oligonucleotide; D019496:Cancer Vaccines; C116055:MUC1 tandem repeat peptide; D018396:Mucin-1; D009838:Oligodeoxyribonucleotides; D010446:Peptide Fragments; D016178:Granulocyte-Macrophage Colony-Stimulating Factor
references: Gastroenterology. 2003 Mar;124(3):762-77
references: 12612914
references: Gut. 2002 Jun;50(6):857-60
references: 12010890
references: Oncogene. 2003 May 19;22(20):3188-92
references: 12789295
references: Glycoconj J. 2001 Nov-Dec;18(11-12):931-42
references: 12820727
references: Clin Cancer Res. 2003 Jul;9(7):2693-700
references: 12855649
references: Nat Med. 2004 Feb;10(2):187-92
references: 14745443
references: Adv Immunol. 2004;82:249-93
references: 14975259
references: Proc Natl Acad Sci U S A. 1989 Sep;86(18):7159-63
references: 2674949
references: Science. 1990 Jan 19;247(4940):322-4
references: 2296722
references: N Engl J Med. 1993 May 6;328(18):1313-6
references: 8385741
references: Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3539-43
references: 8097319
references: J Immunol. 1993 Oct 1;151(7):3693-703
references: 7690810
references: Gastroenterology. 1994 Feb;106(2):353-61
references: 7905449
references: Gastroenterology. 1994 Oct;107(4):1183-8
references: 7926468
references: Cancer Res. 1995 Jun 15;55(12):2556-9
references: 7780968
references: Cancer Immunol Immunother. 1996 Jun;42(5):303-9
references: 8706053
references: Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10972-7
references: 8855293
references: Oncol Res. 1996;8(2):53-61
references: 8859775
references: Cell. 1996 Nov 29;87(5):803-9
references: 8945508
references: J Exp Med. 1997 Nov 17;186(10):1623-31
references: 9362523
references: Tumour Biol. 1998;19 Suppl 1:1-20
references: 9422084
references: Cancer Res. 1998 Jan 15;58(2):315-21
references: 9443411
references: Hum Gene Ther. 1998 Apr 10;9(6):835-43
references: 9581906
references: J Immunol. 1999 Mar 15;162(6):3388-94
references: 10092793
references: Int Arch Allergy Immunol. 1999 Feb-Apr;118(2-4):457-61
references: 10224474
references: Carcinogenesis. 1999 Jul;20(7):1277-82
references: 10383901
references: Endoscopy. 1999 Aug;31(6):472-8
references: 10494690
references: JAMA. 1999 Oct 6;282(13):1254-7
references: 10517428
references: J Clin Invest. 2005 Mar;115(3):739-46
references: 15696196
references: N Engl J Med. 2005 Mar 17;352(11):1071-80
references: 15713944
references: N Engl J Med. 2006 Aug 31;355(9):873-84
references: 16943400
references: Vaccine. 2007 Feb 19;25(9):1607-18
references: 17166639
references: Cancer Res. 2007 Feb 1;67(3):1326-34
references: 17283170
references: J Immunother. 1999 Sep;22(5):431-40
references: 10546159
references: Am J Pathol. 2000 Feb;156(2):545-53
references: 10666384
references: J Immunother. 2000 Mar-Apr;23(2):255-66
references: 10746552
references: Nat Biotechnol. 2000 May;18(5):509-14
references: 10802617
references: J Immunol. 2000 Jul 1;165(1):539-47
references: 10861094
references: N Engl J Med. 2000 Jun 29;342(26):1946-52
references: 10874062
references: J Immunol. 2000 Sep 15;165(6):3451-60
references: 10975866
references: J Immunol. 2000 Dec 1;165(11):6244-51
references: 11086059
references: Cancer Res. 2001 Feb 15;61(4):1733-40
references: 11245490
references: Histopathology. 2002 May;40(5):440-9
references: 12010364
references: J Clin Oncol. 2002 Jun 1;20(11):2624-32
references: 12039923
references: Biochemistry. 2002 Aug 6;41(31):9946-61
references: 12146959
references: J Immunother. 2003 Jan-Feb;26(1):47-62
references: 12514429
references: Clin Cancer Res. 2001 Mar;7(3 Suppl):848s-855s
references: 11300482
references: J Immunol. 2002 Feb 1;168(3):1212-8
references: 11801657
references: Clin Cancer Res. 2002 May;8(5):967-72
references: 12006508
references: Immunology. 2003 Jun;109(2):300-7
references: 12757626